Tampa, FL, United States of America

Laurel L Sandler

This inventor holds 1 USPTO granted patent. Top assignee: University of South Florida. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurel L Sandler. Retrieved from https://idiyas.com/inventor/laurel-l-sandler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Laurel L Sandler

Introduction

Laurel L Sandler is a prominent inventor based in Tampa, Florida. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and nucleic acids. Her work focuses on understanding and manipulating cellular processes, which has implications for various medical applications.

Latest Patents

Laurel L Sandler holds a patent for her invention titled "POP2: NKκB-inhibiting polypeptides, nucleic acids and methods of use." This invention provides a novel pyrin-only protein (POP2), polypeptides, and nucleic acids encoding them, along with methods for making and using them. POP2 is a 294 nt single exon gene located on human chromosome 3, encoding a 97 amino acid protein with sequence and predicted structural similarity to other pyrin domains. It is highly similar to pyrin domains in CATERPILLER (CLR, NLR, NALP) family proteins, while being less like the prototypic Pyrin and ASC pyrin domains. POP2 is principally expressed in peripheral blood leukocytes and displays both cytoplasmic and nuclear expression patterns in transfected cells. The invention reveals that TNFα-stimulated and p65 (RelA) induced NF-κB-dependent gene transcription is inhibited by POP2 in vitro through a mechanism involving changes in NF-κB nuclear import or distribution. Additionally, while colocalizing with ASC in perinuclear specks, POP2 inhibits the formation of specks by the CLR protein CIAS1/NALP3. POP2 serves as a negative regulator of NF-κB activity, potentially influencing the assembly of pyrin-domain dependent complexes.

Career Highlights

Laurel L Sandler is affiliated with the University of South Florida, where she continues her research and innovation in the field of biotechnology. Her work has garnered attention for its potential applications in therapeutic interventions and understanding complex cellular mechanisms.

Collaborations

Laurel has collaborated with notable colleagues, including Jonathan A Harton and Felipe Bedoya, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Laurel L Sandler's contributions to biotechnology through her patent on POP2 exemplify her innovative spirit and dedication to advancing scientific knowledge. Her work not only enhances our understanding of cellular processes but also opens

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…